PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 33 filers reported holding PHARMACYTE BIOTECH INC in Q4 2023. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 276,992 | $792,197 | 4.95% |
| K2 PRINCIPAL FUND, L.P. | 154,232 | $441,104 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 61,415 | $175,647 | 0.05% |
| CSS LLC/IL | 13,186 | $37,712 | 0.00% |
| Covestor Ltd | 189 | $1 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,500 | $67,210 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,288 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 54 | $154 | 0.00% |
| WELLS FARGO & COMPANY/MN | 185 | $529 | 0.00% |
| NORTHERN TRUST CORP | 28,415 | $81,267 | 0.00% |